Versor Investments LP purchased a new stake in Dolby Laboratories (NYSE:DLB - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 22,087 shares of the electronics maker's stock, valued at approximately $1,774,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of DLB. Alpine Bank Wealth Management acquired a new stake in shares of Dolby Laboratories during the 1st quarter worth $25,000. Cheviot Value Management LLC acquired a new stake in shares of Dolby Laboratories in the first quarter worth $27,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Dolby Laboratories in the 1st quarter valued at $29,000. Global X Japan Co. Ltd. acquired a new position in shares of Dolby Laboratories during the 1st quarter valued at $51,000. Finally, Fifth Third Bancorp boosted its position in Dolby Laboratories by 84.7% during the 1st quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock worth $53,000 after purchasing an additional 305 shares during the period. Institutional investors and hedge funds own 58.56% of the company's stock.
Dolby Laboratories Stock Performance
Shares of NYSE DLB traded down $0.3670 during trading on Wednesday, reaching $73.4330. The stock had a trading volume of 511,476 shares, compared to its average volume of 428,494. The firm's 50 day moving average price is $74.37 and its two-hundred day moving average price is $76.83. Dolby Laboratories has a one year low of $68.24 and a one year high of $89.66. The stock has a market cap of $7.04 billion, a PE ratio of 26.90 and a beta of 0.91.
Dolby Laboratories (NYSE:DLB - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. During the same quarter in the prior year, the business earned $0.71 earnings per share. Dolby Laboratories's quarterly revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th will be given a dividend of $0.33 per share. The ex-dividend date is Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. Dolby Laboratories's dividend payout ratio is currently 48.35%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Tigress Financial increased their target price on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Wall Street Zen cut shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Friday, May 2nd. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $103.00.
View Our Latest Stock Report on DLB
Insider Activity
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,295,764.75. The trade was a 17.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 15,000 shares of the company's stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the completion of the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at approximately $4,681,022.94. This trade represents a 19.38% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 141,049 shares of company stock worth $10,521,141. 38.39% of the stock is currently owned by insiders.
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.